J&J unit recalls potentially leaky insulin pump cartridges

Johnson & Johnson just can't seem to get a win; a unit of the pharma and medical device giant has recalled more than 380,000 potentially leaky insulin pump cartridges. And the recall comes with the disclosure of a warning letter to J&J's Cordis unit.

In a Feb. 24 letter, J&J unit Animas notified patients of the problem, saying the recall affects 2-milliliter cartridges shipped between Nov. 30 and Jan. 4. These cartridges can leak, resulting in the delivery of less insulin than intended. The letter states the under-delivery of insulin can cause high blood sugar and diabetic ketoacidosis--serious conditions that can lead to severe health issues, including death. In addition, if the cartridge has a leak, the pump may not alarm if there is a blockage in the infusion set, the letter said.

Animas spokeswoman Caroline Pavis told Reuters a total of 384,180 cartridges were recalled. They came from from five lots shipped in the U.S. and one in France. According to Pavis, there have been reports of 22 adverse events, but none involved hospitalization or death. She added the company became aware of the problem through customer complaints about insulin leaking from the plunger side of the cartridge.

- see the Animas letter
- get more from Reuters
-
read the story from Bloomberg

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.